Bahri Ülküseven
Research Subjects
Bahri Ülküseven has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Tülay Bal‐Demirci
İstanbul Üniversitesi-Cerrahpaşa
31 shared publications - Namık Özdemir
Department of Physics, Faculty of Science, Ondokuz Mayıs University, Samsun, Türkiye
29 shared publications Şükriye Güveli
20 shared publicationsMusa Şahin
12 shared publications- Yasemin Dasdemir Kurt
Department of Chemistry , Istanbul University , 34320 Avcılar, Istanbul, Turkey
12 shared publications - Büşra Kaya
Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD 4215, Australia
11 shared publications
Latest Publications
- 12 February 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1362
Copper(II) and zinc(II) complexes of N2O2-thiosemicarbazones as inhibitors of Mycobacterium tuberculosis and bacterial quorum sensing
- 12 February 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1362
Copper(II) and zinc(II) complexes of N2O2-thiosemicarbazones as inhibitors of Mycobacterium tuberculosis and bacterial quorum sensing
- 15 January 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1358
Analysis of biomolecular changes in palladium-treated colorectal cancer cells compared with cisplatin groups via FTIR spectroscopy
- 15 January 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1358
Analysis of biomolecular changes in palladium-treated colorectal cancer cells compared with cisplatin groups via FTIR spectroscopy
- Open Access
- 1 December 2025
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 12 (4) , 221-234
The Effects of Thiosemicarbazone-based Oxovanadium (IV) Complex on the Lens and Skin Tissues in Streptozotocin-Induced Diabetic Rats and Computational Studies for the Key Target Proteins of the Lens Tissues
A vanadium compound, 2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-isothiosemicarbazidato-oxidovanadium(IV) (VOL), was investigated for its possible benefits in the treatment of diabetes-related symptoms. Male Swiss albino rats aged 3 to 3.5 months were used in the study. The animals were randomly assigned to four groups. Experimental diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ) at a dose of 65 mg/kg. The groups were as follows: Group I – healthy control (no treatment); Group II – healthy control rats administered VOL; Group III – STZ-induced diabetic rats; Group IV – STZ-induced diabetic rats treated with VOL. After diabetes was induced, VOL was administered to the rats in Groups II and IV via gavage at a daily dose of 0.2 mM/kg for 12 consecutive days. Based on biochemical results, in lens and skin tissues, reduced glutathione levels, catalase, and superoxide dismutase activities were increased, whereas lipid peroxidation and non-enzymatic glycosylated levels were decreased in VOL-treated diabetic rats. Besides that, enzyme activities in the polyol pathway decreased in the lens tissues of diabetic animals given VOL. The binding affinities of these two enzymes (AR and SDH) to VOL were also investigated using molecular docking based on the conformational state. The results revealed that the use of VOL can be effective in preventing or at least retarding the development of some diabetic ocular and dermal complications.
- 1 December 2025
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 12 (4) , 221-234
Open AccessThe Effects of Thiosemicarbazone-based Oxovanadium (IV) Complex on the Lens and Skin Tissues in Streptozotocin-Induced Diabetic Rats and Computational Studies for the Key Target Proteins of the Lens Tissues
A vanadium compound, 2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-isothiosemicarbazidato-oxidovanadium(IV) (VOL), was investigated for its possible benefits in the treatment of diabetes-related symptoms. Male Swiss albino rats aged 3 to 3.5 months were used in the study. The animals were randomly assigned to four groups. Experimental diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ) at a dose of 65 mg/kg. The groups were as follows: Group I – healthy control (no treatment); Group II – healthy control rats administered VOL; Group III – STZ-induced diabetic rats; Group IV – STZ-induced diabetic rats treated with VOL. After diabetes was induced, VOL was administered to the rats in Groups II and IV via gavage at a daily dose of 0.2 mM/kg for 12 consecutive days. Based on biochemical results, in lens and skin tissues, reduced glutathione levels, catalase, and superoxide dismutase activities were increased, whereas lipid peroxidation and non-enzymatic glycosylated levels were decreased in VOL-treated diabetic rats. Besides that, enzyme activities in the polyol pathway decreased in the lens tissues of diabetic animals given VOL. The binding affinities of these two enzymes (AR and SDH) to VOL were also investigated using molecular docking based on the conformational state. The results revealed that the use of VOL can be effective in preventing or at least retarding the development of some diabetic ocular and dermal complications.
- 5 August 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1349
Synthesis and enzyme inhibitory activities of Ni(II)-thiosemicarbazone complexes: [NiC]·2H₂O, [NiC], [NiC(H₂O)]
- 5 August 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1349
Synthesis and enzyme inhibitory activities of Ni(II)-thiosemicarbazone complexes: [NiC]·2H₂O, [NiC], [NiC(H₂O)]
- 19 September 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1321
A square planar cobalt(II)-thiosemicarbazone complex. Synthesis, characterization, antiviral and anti-inflammatory potential
- 19 September 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1321
A square planar cobalt(II)-thiosemicarbazone complex. Synthesis, characterization, antiviral and anti-inflammatory potential
- Open Access
- 29 February 2024
- Published by Sakarya University Journal of Science in Sakarya University Journal of Science
- Vol. 28 (1) , 133-144
Ameliorative Effect of a Vanadium-thiosemicarbazone Complex on Oxidative Stress in Stomach Tissue of Experimental Diabetic Rats
Recently, we have shown that oral administrations of an oxidovanadium (IV) complex, VOL, with tetradentate thiosemicarbazone ligand normalizes hyperglycemia of streptozotocin-induced diabetic rats (STZ-rats). For the development of vanadium compounds that exhibit insulin-like behavior, it is essential to know some of the pharmacokinetic properties of these complexes. The goal of the current research is to examine the healing effect of new sythesed VOL complex on the oxidative stress parameters of diabetic stomac tissue. Rats used in the experiments were divided as control, VOL+control, diabetic and diabetic+VOL. The rats were sacrificed after 12 days of the experimental period. The levels of glutathione, lipid peroxidation, non-enzymatic glycosylation, advanced oxidized protein products levels and the activities of some enzymes were measured in stomach tissue of all the experimental animals. Although VOL treatment to diabetic rats increased the stomach glutathione levels; lipid peroxidation, non-enzymatic glycosylation and advanced oxidized protein products levels were decreased. Also, the activities of catalase, superoxide dismutase, glutathione-S-transferase, glutathione peroxidase, glutathione reductase and carbonic anhydrase were increased in VOL treated diabetic group. Whereas, lactate dehydrogenase and xanthine oxidase activities were decreased. According to the obtained outcomes, it can be said that VOL treatment has a healing effect on the stomach tissue of diabetic rats. This effect provided by VOL is most likely due to the insulin-like and antioxidant activity of the complex. In conclusion, we can say that VOL may be a suitable candidate for diabetes treatment.
- 29 February 2024
- Published by Sakarya University Journal of Science in Sakarya University Journal of Science
- Vol. 28 (1) , 133-144
Open AccessAmeliorative Effect of a Vanadium-thiosemicarbazone Complex on Oxidative Stress in Stomach Tissue of Experimental Diabetic Rats
Recently, we have shown that oral administrations of an oxidovanadium (IV) complex, VOL, with tetradentate thiosemicarbazone ligand normalizes hyperglycemia of streptozotocin-induced diabetic rats (STZ-rats). For the development of vanadium compounds that exhibit insulin-like behavior, it is essential to know some of the pharmacokinetic properties of these complexes. The goal of the current research is to examine the healing effect of new sythesed VOL complex on the oxidative stress parameters of diabetic stomac tissue. Rats used in the experiments were divided as control, VOL+control, diabetic and diabetic+VOL. The rats were sacrificed after 12 days of the experimental period. The levels of glutathione, lipid peroxidation, non-enzymatic glycosylation, advanced oxidized protein products levels and the activities of some enzymes were measured in stomach tissue of all the experimental animals. Although VOL treatment to diabetic rats increased the stomach glutathione levels; lipid peroxidation, non-enzymatic glycosylation and advanced oxidized protein products levels were decreased. Also, the activities of catalase, superoxide dismutase, glutathione-S-transferase, glutathione peroxidase, glutathione reductase and carbonic anhydrase were increased in VOL treated diabetic group. Whereas, lactate dehydrogenase and xanthine oxidase activities were decreased. According to the obtained outcomes, it can be said that VOL treatment has a healing effect on the stomach tissue of diabetic rats. This effect provided by VOL is most likely due to the insulin-like and antioxidant activity of the complex. In conclusion, we can say that VOL may be a suitable candidate for diabetes treatment.
- 21 August 2023
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (5) , 2085-2099
Antioxidant Activity and Protective Effects of an Oxovanadium (IV) Complex on Heart and Aorta Injury of STZ-Diabetic Rats
Diabetic people have a much higher rate of cardiovascular disease than healthy people. Therefore, heart and aortic tissues are target tissues in diabetic research. In recent years, the synthesis of new vanadium complexes and investigation of their antidiabetic/lowering effect on the blood glucose levels and antioxidant properties are increasing day by day. Our study aimed to examine the effects of synthesized oxovanadium (IV) complex of 2-[(2,4-dihydroxybenzylidene]hydrazine-1-[(N-(2-hydroxybenzylidene)](S-methyl)carbothioamide [VOL] on diabetic heart and aortic tissues, as well as in vitro lactate dehydrogenase (LDH) and myeloperoxidase (MPO) inhibition, antioxidant properties, and reducing power. Electrochemical characterization of the VOL was carried out by using Cyclic Voltammetry (CV) and Linear Sweep Voltammetry (LSV) methods. In addition, in silico drug-likeness and ADME prediction were also investigated. For in vivo study, male Swiss albino rats were randomly selected and separated into four groups which are control, control + VOL, diabetic and diabetic + VOL. After the experimental procedure, biochemical parameters were investigated in homogenates of heart and aorta tissues. The results showed that VOL has a protective effect on heart and aortic tissue against oxidative stress. According to electrochemical experiments, one reversible oxidative couple and one irreversible reductive response were observed for the complex. In addition, in vitro LDH and MPO inhibition of VOL was examined. It was found that VOL had a protective effect on heart and aortic tissues of diabetic rats, and caused the inhibition of LDH and MPO in in vitro studies. On the other hand, evaluating the synthesized VOL according to in silico drug-likeness and absorption, distribution, metabolism, and excretion (ADME) prediction, it was found that VOL has drug-like properties and exhibited high gastrointestinal absorption. The VOL had a therapeutic impact on the heart and aortic tissues of diabetic rats, according to the findings.
- 21 August 2023
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (5) , 2085-2099
Antioxidant Activity and Protective Effects of an Oxovanadium (IV) Complex on Heart and Aorta Injury of STZ-Diabetic Rats
Diabetic people have a much higher rate of cardiovascular disease than healthy people. Therefore, heart and aortic tissues are target tissues in diabetic research. In recent years, the synthesis of new vanadium complexes and investigation of their antidiabetic/lowering effect on the blood glucose levels and antioxidant properties are increasing day by day. Our study aimed to examine the effects of synthesized oxovanadium (IV) complex of 2-[(2,4-dihydroxybenzylidene]hydrazine-1-[(N-(2-hydroxybenzylidene)](S-methyl)carbothioamide [VOL] on diabetic heart and aortic tissues, as well as in vitro lactate dehydrogenase (LDH) and myeloperoxidase (MPO) inhibition, antioxidant properties, and reducing power. Electrochemical characterization of the VOL was carried out by using Cyclic Voltammetry (CV) and Linear Sweep Voltammetry (LSV) methods. In addition, in silico drug-likeness and ADME prediction were also investigated. For in vivo study, male Swiss albino rats were randomly selected and separated into four groups which are control, control + VOL, diabetic and diabetic + VOL. After the experimental procedure, biochemical parameters were investigated in homogenates of heart and aorta tissues. The results showed that VOL has a protective effect on heart and aortic tissue against oxidative stress. According to electrochemical experiments, one reversible oxidative couple and one irreversible reductive response were observed for the complex. In addition, in vitro LDH and MPO inhibition of VOL was examined. It was found that VOL had a protective effect on heart and aortic tissues of diabetic rats, and caused the inhibition of LDH and MPO in in vitro studies. On the other hand, evaluating the synthesized VOL according to in silico drug-likeness and absorption, distribution, metabolism, and excretion (ADME) prediction, it was found that VOL has drug-like properties and exhibited high gastrointestinal absorption. The VOL had a therapeutic impact on the heart and aortic tissues of diabetic rats, according to the findings.
- 9 June 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (30) , 14225-14241
In vitrobiological andin silicoscreening of novel iron(iii) complexes for DNA-targeted antitumor drug component
Two novel thiosemicarbazone-based iron(III) complexes (Fe1 and Fe2) were synthesized and identified by analytical and spectroscopic methods. Their antiproliferative activity was investigated using the 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) test against HT-29, HeLa, and L929 cell lines. The interaction between the complexes and calf thymus DNA were determined using electronic spectra and fluorescence spectra analysis. Gel electrophoresis was used to examine DNA cleavage and human topoisomerase-IIα inhibitory action. The complexes were screened for xanthine oxidase (XO) inhibitory activity and their antioxidant activities were determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and phosphomolybdenum methods. In silico screening was performed to evince some pharmacological characteristics such as drug-likeness, bioactivity score and probable activity spectra of compounds (PASS) analysis using Molinspiration and PASS software. The iron(III) complexes promoted the cleavage of DNA from the supercoiled form (Form I) to the nicked circular form (Form II), but did not create Form III, indicating single-stranded DNA cleavage. MTT results showed that Fe2 has more effective antiproliferative activity on HT-29 cells, Fe1 has more effective antiproliferative activity on HeLa cells, and the complexes generally moderately affect normal fibroblast L929 cells. The antiproliferation levels were consistent with the DNA interaction results. Both complexes had antioxidant activity and inhibited XO better than the standard drug allopurinol. In silico studies have shown that the iron(III) complexes can have drug-like characteristics associated with remarkable pharmacokinetic properties that make sense of the experimental data regarding DNA-targeting, antioxidant, topoisomerase-IIα and XO inhibitory abilities.
- 9 June 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (30) , 14225-14241
In vitrobiological andin silicoscreening of novel iron(iii) complexes for DNA-targeted antitumor drug component
Two novel thiosemicarbazone-based iron(III) complexes (Fe1 and Fe2) were synthesized and identified by analytical and spectroscopic methods. Their antiproliferative activity was investigated using the 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) test against HT-29, HeLa, and L929 cell lines. The interaction between the complexes and calf thymus DNA were determined using electronic spectra and fluorescence spectra analysis. Gel electrophoresis was used to examine DNA cleavage and human topoisomerase-IIα inhibitory action. The complexes were screened for xanthine oxidase (XO) inhibitory activity and their antioxidant activities were determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and phosphomolybdenum methods. In silico screening was performed to evince some pharmacological characteristics such as drug-likeness, bioactivity score and probable activity spectra of compounds (PASS) analysis using Molinspiration and PASS software. The iron(III) complexes promoted the cleavage of DNA from the supercoiled form (Form I) to the nicked circular form (Form II), but did not create Form III, indicating single-stranded DNA cleavage. MTT results showed that Fe2 has more effective antiproliferative activity on HT-29 cells, Fe1 has more effective antiproliferative activity on HeLa cells, and the complexes generally moderately affect normal fibroblast L929 cells. The antiproliferation levels were consistent with the DNA interaction results. Both complexes had antioxidant activity and inhibited XO better than the standard drug allopurinol. In silico studies have shown that the iron(III) complexes can have drug-like characteristics associated with remarkable pharmacokinetic properties that make sense of the experimental data regarding DNA-targeting, antioxidant, topoisomerase-IIα and XO inhibitory abilities.
- 1 February 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (4)
Synthesis, SARS‐CoV‐2 3CL main protease inhibitor, anti‐inflammatory, and wound‐healing effects of a zinc(II)‐thiosemicarbazone complex
A new zinc(II) complex with tetradentate thiosemicarbazone (2) was synthesized to investigate the effectiveness against SARS‐CoV‐2 virus and its anti‐inflammatory effects on BEAS‐2B human bronchial epithelial cells. Structural confirmation was performed by IR, 1H and 13C NMR, and ESI‐MS spectroscopies. The results showed that the complex 2 molecule inhibits 3CL main protease enzyme. It was found that complex 2 had a proliferative effect at low doses. TNF‐α stimulation significantly increased IL8 gene expression 3.42 ± 0.107 fold in BEAS‐2B cells (p = 0.037). However, it was found that all concentrations of complex 2 highly suppressed IL8 gene expression in the control group and TNF‐α‐stimulated BEAS‐2B cells (p = 0.009). The healing rate of complex 2 was higher than the control and BEAS‐2B cells induced by TNF‐α at the 24 and 48 h after wound formation. It is known that the biological efficiency of metal‐thiosemicarbazone complexes was adjusted depending on substituent and metal. In this context, complex 2 may be considered as a precursor molecule in the investigation of the antiviral and anti‐inflammatory effects of those formed with the element zinc. Investigation of the selectivity of the inhibitory effect of complex 2 on the 3CL main protease is important for a more detailed understanding of its antiviral effect potential. Although the 3CL main protease enzyme was concentrated in antiviral effective molecule screening studies against SARS‐CoV‐2 virus, the fact that complex 2 also has anti‐inflammatory and wound‐healing effects is a distinguishing feature from other inhibitory effective molecules.
- 1 February 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (4)
Synthesis, SARS‐CoV‐2 3CL main protease inhibitor, anti‐inflammatory, and wound‐healing effects of a zinc(II)‐thiosemicarbazone complex
A new zinc(II) complex with tetradentate thiosemicarbazone (2) was synthesized to investigate the effectiveness against SARS‐CoV‐2 virus and its anti‐inflammatory effects on BEAS‐2B human bronchial epithelial cells. Structural confirmation was performed by IR, 1H and 13C NMR, and ESI‐MS spectroscopies. The results showed that the complex 2 molecule inhibits 3CL main protease enzyme. It was found that complex 2 had a proliferative effect at low doses. TNF‐α stimulation significantly increased IL8 gene expression 3.42 ± 0.107 fold in BEAS‐2B cells (p = 0.037). However, it was found that all concentrations of complex 2 highly suppressed IL8 gene expression in the control group and TNF‐α‐stimulated BEAS‐2B cells (p = 0.009). The healing rate of complex 2 was higher than the control and BEAS‐2B cells induced by TNF‐α at the 24 and 48 h after wound formation. It is known that the biological efficiency of metal‐thiosemicarbazone complexes was adjusted depending on substituent and metal. In this context, complex 2 may be considered as a precursor molecule in the investigation of the antiviral and anti‐inflammatory effects of those formed with the element zinc. Investigation of the selectivity of the inhibitory effect of complex 2 on the 3CL main protease is important for a more detailed understanding of its antiviral effect potential. Although the 3CL main protease enzyme was concentrated in antiviral effective molecule screening studies against SARS‐CoV‐2 virus, the fact that complex 2 also has anti‐inflammatory and wound‐healing effects is a distinguishing feature from other inhibitory effective molecules.